Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtful

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 192-198

  Searle, Karen ^a   Schalasta, Gunnar ^a   Enders, Gisela ^a  

^a Institut fur Virologie   (Germany)

Author keywords

Antibodies; Nonstructural protein; Parvovirus

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN;

ADULT; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNE RESPONSE; PARVOVIRUS; PATHOGENESIS; PREGNANCY;

ACUTE DISEASE; ANTIBODIES, VIRAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL DISEASES; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTERS; VIRAL NONSTRUCTURAL PROTEINS;

DNA VIRUSES; PARVOVIRUS;

EID: 0031670835     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<192::AID-JMV3>3.0.CO;2-2     Document Type: Article

References (17)

1. Anderson MJ, Jones SE, Fischer-Hoch SP, Lewis E, Hall SM, Bartlett CLR, Cohen BJ, Mortimer PP, Periera MS (1983): Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet ii:1378.
2. Brown KE, Green SW, Antuncz de Mayolo J, Bellanti JA, Smith SD, Smith TJ, Young NS (1994): Congenital anaemia after transplancental B19 parvovirus infection. Lancet 343:895-896.
3. Enders G (1998): Infections of the fetus and neonate other than rubella. In Collier L (ed): "Topley & Wilson's Microbiology and Microbial Infections," 9th ed. London: Edward Arnold, pp 890-891.
4. Enders G, Dötsch J, Bauer J, Nützenadel W, Hengel H, Haffner D, Schalasta G, Searle K, Brown KE (1998): Two case reports: Life-threatening parvovirus B19 associated myocarditis and cardiac transplantation as a possible therapy. Clinical Infectious Diseases 26:355-358.
5. Fairley CK, Smoleneic JS, Miller E (1995): Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 18:1335-1337.
6. Finkel TH, Török T, Ferguson PJ, Durigon EL, Zaki SR, Leung DYM, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR, Anderson LJ (1994): Chronic parvovirus B19 infection and systemic nerotising vasculitis: Opportunistic infection or aetiological agent? Lancet 343:1255-1258.
7. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE (1981): Parvovirus infection and hypoplastic crisis in sickle cell anaemia. Lancet i:664-665.
8. Poblotzki A, Gigler A, Lang B, Wolf H, Modrow S (1995a): Antibodies to the non-structural protein NS-1 of parvovirus B19 in infected individuals. Journal of General Virology 76:519-527.
9. Poblotzki A, Hemauer A, Gigler A, Puchhammer-Stöckl E, Heinz FX, Pont J, Laczika K, Wolf H, Modrow S (1995b): Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis. Journal of Infectious Disease 172:1356-1359.
10. Public Health Laboratory Working Party of Fifth Disease (1990): Prospective study of human parvovirus (B19) infection in pregnancy. British Medical Journal 300:1166-1170.
11. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ (1985): Human parvovirus-associated arthritis: A clinical and laboratory description. Lancet i:422-425.
12. Schwarz TF, Nerlich A, Roggendorf H, Hottenträger B, Jäger G, Schramm T, Gloning KP, Roggendorf M (1990): Parvovirus B19 infection in pregnancy. International Journal of Experimental and Clinical Chemotherapy 3:219-223.
13. Searle K, Guilliard C, Enders G (1997): Parvovirus B19 diagnosis in pregnant women - Quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum. Infection 25:32-34.
14. Searle K, Guilliard C, Wallat S, Schalasta G, Enders G (1998): Acute parvovirus B19 infection in pregnant women - An analysis of serial samples by serological and semi-quantitative PCR techniques. Infection 26:139-143.
15. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA (1985): Human parvovirus arthropathy. Lancet i:419-421.
16. Woolf AD, Campion GV, Chishick A, Wise S (1989): Clinical manifestations of human parvovirus B19 in adults. Archives of International Medicine 149:1153-1156.
17. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S (1996): Human parvovirus B19 infection associated with acute hepatitis. Lancet 346:868-869.